Information for ActX Select participants
The ActX Select Service includes both genotyping and the ActX Genomics Service and is our initial pilot offering. Your DNA will be examined by genotyping. The genotyping is done by a CLIA certified laboratory using ActX’s custom micro-array. Please note that genotyping, while affordable, looks only at selected genetic variants (SNPs) and does not cover every possible variant or gene. ActX Select includes a free time limited trial subscription to the ActX Genomic Service. After the free trial, if you choose to continue with the Service, then there will be an annual fee.
The ActX Genomic Service provides a real time, frequently updated analysis of the genotyping. The analysis will initially cover many medication-genetic interactions and heritable cancer risks. Without the need for further testing, the analysis will be updated as the ActX knowledgebase grows. For example it will soon cover many cardiac risks, and many other actionable genetic risks and conditions. As medical knowledge of evidence based, actionable, genetic risks advances, the ActX knowledgebase will be updated and contribute to your ActX analysis. You and your authorizing physician will be notified of any important new findings about your personal genetics.
Both you and your authorizing physician will be able to see and review your genomic data using a secure website. Your genomic data will also be available to other physicians that you select. While at first, some participating physicians will view your data and check medications on a secure website, they will later be able to view your data within their Electronic Medical Record (EMR) once their EMR system integrates with ActX. When ActX is integrated within your physician’s Electronic Medical Record, then prescriptions will be checked automatically for an interaction with your genetics.
In order to sign up for the ActX Service, you must be authorized by a physician.
The ActX Select Service includes both genotyping and the ActX Genomics Service and is our initial pilot offering. Your DNA will be examined by genotyping. The genotyping is done by a CLIA certified laboratory using ActX’s custom micro-array. Please note that genotyping, while affordable, looks only at selected genetic variants (SNPs) and does not cover every possible variant or gene. ActX Select includes a free time limited trial subscription to the ActX Genomic Service. After the free trial, if you choose to continue with the Service, then there will be an annual fee.
The ActX Genomic Service provides a real time, frequently updated analysis of the genotyping. The analysis will initially cover many medication-genetic interactions and heritable cancer risks. Without the need for further testing, the analysis will be updated as the ActX knowledgebase grows. For example it will soon cover many cardiac risks, and many other actionable genetic risks and conditions. As medical knowledge of evidence based, actionable, genetic risks advances, the ActX knowledgebase will be updated and contribute to your ActX analysis. You and your authorizing physician will be notified of any important new findings about your personal genetics.
Both you and your authorizing physician will be able to see and review your genomic data using a secure website. Your genomic data will also be available to other physicians that you select. While at first, some participating physicians will view your data and check medications on a secure website, they will later be able to view your data within their Electronic Medical Record (EMR) once their EMR system integrates with ActX. When ActX is integrated within your physician’s Electronic Medical Record, then prescriptions will be checked automatically for an interaction with your genetics.
In order to sign up for the ActX Service, you must be authorized by a physician.
Follow
Copyright © 2014 - 2026 ActX, Inc.